Biomaterials for intranasal and inhaled vaccine delivery.
Devorah CahnMayowa AmosuKatharina MaiselGregg A DuncanPublished in: Nature reviews bioengineering (2023)
Delivery of vaccines by nasal sprays may enable more robust, protective mucosal immune responses against infectious diseases, such as COVID-19, compared with intramuscular injection. In this Comment, we highlight how biomaterials can be designed to allow intranasal and inhaled vaccination.